.avif)
April 5, 2024
Defective Pinnacle Ultamet Hip Replacement System Lawsuit Lawyers
Parker Waichman LLP is actively representing victims of the defective Pinnacle Ultamet hip replacement system, manufactured by DePuy, a Johnson & Johnson subsidiary. Evidence presented in a UK court revealed flaws in DePuy's safety testing, leading to numerous personal injury claims. The metal-on-metal design of the hip replacement has been linked to elevated cobalt and chromium levels in patients' blood, causing health issues and necessitating additional surgeries. Parker Waichman LLP is committed to securing compensation for affected individuals, challenging large corporations like DePuy and Johnson & Johnson.
Parker Waichman LLP: Advocating for Victims of Defective Pinnacle Ultamet Hip Replacement Systems
April 5, 2024
Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
The Judicial Panel on Multidistrict Litigation has established an MDL in New York to address claims of diabetic ketoacidosis and kidney damage allegedly caused by the diabetes drugs Farxiga and Xigduo XR, manufactured by Bristol-Myers Squibb and AstraZeneca. Eighteen cases are involved, with Judge Lorna G. Schofield presiding. These drugs, SGLT2 inhibitors, lower blood glucose but may lead to ketoacidosis and kidney damage. The FDA has issued warnings and received reports of serious side effects, including acute kidney injury, prompting revised labeling and recommendations for healthcare professionals.
Farxiga and Xigduo Diabetes Lawsuit: MDL Established in New York for Ketoacidosis and Kidney Damage Claims
April 5, 2024
Hip Implant Cobalt Poisoning Lawsuit Lawyers
The New York Times article discusses the dangers of metal-on-metal hip implants, focusing on Dr. Stephen Tower's experience with the defective ASR XL model by Johnson & Johnson. The implant leaked cobalt, causing severe health issues. Despite warnings, Johnson & Johnson continued selling similar models, leading to numerous lawsuits. In 2017, six plaintiffs won a $247 million award. The article highlights the lack of rigorous FDA testing for medical devices, contributing to injuries and deaths. It emphasizes the need for legal action against manufacturers of faulty devices.
Hip Replacements and Cobalt Poisoning: Understanding the Risks and Legal Options
April 5, 2024
California Man Alleges Xarelto Caused Fatal Bleeding in His Mother
A lawsuit has been filed against Janssen Pharmaceuticals, alleging that their anticoagulant drug Xarelto caused a California man's mother to suffer a fatal brain bleed. The lawsuit claims that the manufacturers failed to adequately warn about the risk of uncontrollable bleeding. The plaintiff's mother began taking Xarelto in September 2014 and died shortly after due to an intracranial hemorrhage. Xarelto, a new-generation blood thinner, lacks an antidote to reverse bleeding, unlike warfarin, which can be counteracted with vitamin K. The case is part of a larger multidistrict litigation involving thousands of similar lawsuits.
New Xarelto Lawsuit Alleges Fatal Brain Bleed Due to Blood Thinner's Risks
April 5, 2024
Older Women Face Hip Fracture Risk from PPIs
A study published in the British Medical Journal highlights an increased risk of hip fractures in post-menopausal women taking proton pump inhibitors (PPIs) like Nexium, Prilosec, and Prevacid. Women using PPIs for two years or more have a 35% higher risk, which rises to 50% for those using them for six to eight years. The risk is even greater for smokers. However, the risk returns to normal two years after stopping PPIs. The study involved nearly 80,000 women and recorded 893 hip fractures.
Hip Fracture Risk in Post-Menopausal Women: The Impact of Proton Pump Inhibitors (PPIs)
April 5, 2024
Proton Pump Inhibitor MDL Approved to go Forward in New Jersey
The Proton Pump Inhibitor (PPI) multidistrict litigation (MDL) was consolidated on August 2, 2017, under Judge Claire C. Cecchi in the U.S. District Court of New Jersey. This MDL involves over 163 cases across 28 federal district courts concerning drugs like Prilosec, Nexium, Protonix, and Dexlant. The litigation addresses claims of kidney damage linked to PPI use, with studies indicating increased risks of kidney failure and chronic kidney disease. The FDA mandated warning labels for acute interstitial nephritis in 2014. Defendants include major pharmaceutical companies like AstraZeneca and Pfizer.
Proton Pump Inhibitor MDL Update: Legal Developments, Kidney Damage Warnings, and Lawsuit Insights
April 5, 2024
GeriCare Eye Wash Lawsuit Lawyers
On January 29, 2018, Kareway Products, Inc. recalled over 60,000 lots of GeriCare Eye Wash due to potential microbial contamination, which could lead to serious eye infections. The FDA advised consumers to stop using the product and return it. Parker Waichman LLP is investigating claims related to the recall, offering free legal evaluations for those affected. The recall affects lot #86041601 with an expiration date of 09/2019. Consumers experiencing adverse reactions should contact their healthcare provider and Kareway Products for further guidance.
GeriCare Eye Wash Recall: Urgent Safety Alert for Potential Contamination Risks
April 5, 2024
Free Talcum Powder Case Evaluation
If you or a loved one has ovarian cancer potentially linked to talcum powder use, contact Parker Waichman LLP's Talcum Powder Injury Lawyers promptly to safeguard your compensation rights. Their experienced attorneys specialize in complex cases against large corporations and insurance companies, striving to achieve the best outcomes for their clients. For further assistance, call 1-800-YOURLAWYER (1-800-968-7529) or complete their free case evaluation form.
Talcum Powder and Ovarian Cancer: Consult a Skilled Injury Lawyer for Your Rights and Compensation
April 5, 2024
Monteris Medical NeuroBlate Probe Lawsuit Lawyers
Parker Waichman LLP is evaluating lawsuits related to the Monteris Medical NeuroBlate Probe, a device linked to injuries and one death. The probe, part of a laser thermotherapy system for brain procedures, has been recalled due to overheating issues. The FDA issued a Class I recall, indicating serious risk. Parker Waichman LLP, known for securing over $2 billion for clients, offers free consultations for those affected. They assess potential claims based on factors like injury severity and statute of limitations. Contact them for legal assistance if you have been impacted.
Parker Waichman LLP: NeuroBlate Probe Lawsuits for Injuries and Fatalities Explained
April 5, 2024
Penumbra JET 7 Catheter Injury Lawyers
Penumbra has issued an urgent recall of its JET 7 Reperfusion Catheters with Xtra Flex Technology after the FDA received over 200 reports of serious injuries linked to the device, including blood vessel damage and cerebral infarction. The recall affects the JET 7 Xtra Flex catheter and the JET 7 MAX. Healthcare providers are advised to stop using these devices immediately. Those harmed by the catheter are encouraged to seek legal assistance to pursue compensation for injuries. Parker Waichman LLP offers free consultations for affected individuals.
Urgent Recall of Penumbra JET 7 Catheters: Important Information and Legal Guidance for Affected Patients
April 5, 2024
New Jersey Talcum Powder Ovarian Cancer MDL Continues to Grow
Four additional talcum powder lawsuits have been added to the multidistrict litigation (MDL) in New Jersey, where plaintiffs claim that using talcum powder in the genital area led to ovarian cancer. Johnson & Johnson is accused of not warning consumers about these risks. The U.S. Judicial Panel on Multidistrict Litigation transferred cases from Missouri and Pennsylvania to the MDL. Johnson & Johnson has faced several multimillion-dollar verdicts, including a recent $110 million award. The MDL aims to streamline similar lawsuits, while individual cases remain separate.
Four Additional Talcum Powder Lawsuits Added to New Jersey MDL as Litigation Expands
April 5, 2024
Invokana Lawsuit FAQ
Parker Waichman LLP is a national law firm specializing in products liability, representing victims of Invokana, Invokamet, and Invokamet XR, which have been linked to increased risks of amputations. The firm offers free consultations and works on a contingency-fee basis, meaning clients pay no legal fees unless compensation is recovered. The FDA has issued a "Boxed Warning" for these drugs due to the risk of amputations. Parker Waichman LLP provides experienced legal representation to ensure clients receive the compensation they deserve.
Parker Waichman LLP: Advocating for Invokana Victims Suffering Amputation Side Effects
April 5, 2024
AndroGel Testosterone Lawsuit Lawyers
Hypogonadism, or low testosterone, occurs when the body doesn't produce enough hormones due to issues with the brain, pituitary gland, or testicles. Treatments include injections, gels, pills, patches, and implants, often requiring lifelong use and regular medical follow-ups. Testosterone therapies, like AndroGel, carry risks such as heart attack and stroke, leading to numerous lawsuits against manufacturers. Marketing has led many men to use these therapies without proper diagnosis. Legal actions focus on inadequate safety warnings and misleading marketing practices.
"Understanding Hypogonadism: Risks, Treatment Options, and Lawsuits Related to Testosterone Therapy"
April 5, 2024
Lawsuit Alleges Invokana Caused Stroke
A lawsuit has been filed against Johnson & Johnson and Janssen Pharmaceuticals, alleging that their diabetes drug Invokana caused a stroke. The plaintiff, who began taking Invokana in October 2015, suffered a stroke weeks later. The suit claims the companies failed to warn about cardiovascular risks and did not conduct adequate clinical trials. Invokana, approved in 2013, is part of the SGLT-2 inhibitors class. The Canagliflozin Cardiovascular Assessment Study (CANVAS) indicated a 46% higher stroke risk within the first 30 days of use.
Lawsuit Claims Invokana Diabetes Drug Caused Stroke: Allegations Against Johnson & Johnson
April 5, 2024
Stryker Metal-on-Metal Hip Implant Lawsuits Consolidated
Howmedica Osteonics Corporation, a subsidiary of Stryker, is facing lawsuits due to failures in its LFIT Anatomic Cobalt Chromium V40 femoral heads used in hip replacements. The New Jersey Supreme Court has consolidated these lawsuits into multicounty litigation. Issues with these metal-on-metal implants include taper lock failure, leading to severe pain, metallosis, and the need for revision surgeries. Despite a voluntary recall in 2016, the litigation includes non-recalled components due to similar failure issues. The cases will be tried in New Jersey's Bergen County Superior Court.
Stryker Metal-on-Metal Hip Implant Lawsuits: Consolidation of LFIT V40 Cases and Patient Risks
April 5, 2024
Keytruda Clinical Trial Injury and Death Lawsuit Lawyers
Parker Waichman LLP is handling lawsuits related to injuries and deaths from Keytruda clinical trials, particularly those involving multiple myeloma patients. Keytruda, an intravenous chemotherapy drug by Merck & Co., was tested in combination with other therapies, leading to halted trials in 2017 due to patient deaths. The FDA issued warnings about the risks of using Keytruda with other treatments for multiple myeloma. Legal actions may determine if Merck adequately informed participants of these risks. Parker Waichman LLP offers consultations for affected individuals to explore potential compensation.
Keytruda Clinical Trial Lawsuits | Parker Waichman LLP Legal Help
April 5, 2024
20 Australians Join DePuy ASR Hip Implant Lawsuit
Twenty people in Tasmania have filed a class action lawsuit over the recalled DePuy ASR hip implant. The lead plaintiff, Tammy Stanford, has had three surgeries since receiving the implant in 2005, revealing severe tissue and bone damage. The lawsuit highlights issues with metal debris from the implant entering the bloodstream. An estimated 5,500 Australians have received the implant, which was recalled due to high failure rates. Similar lawsuits are ongoing in the U.S., with DePuy also facing litigation over its Pinnacle hip implant.
Lawsuit Filed by 20 Tasmanians Over Defective DePuy ASR Hip Implants
April 5, 2024
Essure Advocates Say FDA Planned for Panel Meeting to Coincide with Papal Visit
The FDA is facing criticism over Bayer's Essure birth control device, which allegedly caused serious injuries. Women have filed over 5,000 complaints, prompting the FDA to schedule a panel meeting. However, the timing coincides with Pope Francis's address to Congress, leading to concerns about media coverage. The Facebook group "Essure Problems," led by activist Erin Brockovich, is advocating for the device's removal. Bayer acquired Essure in 2013, and despite a study claiming low adverse effects, many women report ongoing issues. Advocacy groups plan a hunger strike to raise awareness.
Essure Birth Control Device: Serious Injuries and FDA Criticism Explained
April 5, 2024
Legislators want FDA to take Essure Off the Market
Bayer's permanent birth control device, Essure, is under scrutiny as Congressman Mike Fitzpatrick plans to introduce legislation to revoke its premarket approval. Approved by the FDA in 2002, Essure has faced numerous complaints, with over 5,000 reported to the FDA. The device involves inserting springs into the fallopian tubes to prevent pregnancy. An FDA advisory panel recommended limited use, but no final decision has been made. The proposed legislation aims to revoke Essure's approval within 60 days, citing concerns over its adverse health effects.
Bayer's Essure Birth Control Device Faces Legislative Push to Remove from Market Amid Safety Concerns
April 5, 2024
Tamiflu Seizure and Side Effects Lawsuits
A Texas child experienced severe side effects, including hallucinations and dangerous behavior, after taking Tamiflu for the flu. Her parents were not adequately warned about these potential risks, despite the drug's packaging warnings. The FDA notes that children and teenagers may be at higher risk for such side effects. In a separate case, a 16-year-old in Indiana exhibited drastic personality changes after taking Tamiflu, leading to his suicide. The manufacturer acknowledges reports of neuropsychiatric events but states these can occur with or without Tamiflu.
Common Flu Medication Tamiflu Linked to Serious Side Effects in Children: Family's Disturbing Experience
April 5, 2024
Medtronic MindFrame Capture LLP Revascularization Device Lawsuit Lawyers
The FDA has issued a Class I recall for Medtronic's MindFrame Capture LLP Revascularization Device due to a defect where the device's material can break and remain in a patient's bloodstream, posing severe risks such as bleeding, additional blockages, severe strokes, or death. The device, used for restoring blood flow in ischemic stroke patients, was manufactured between February 2016 and January 2018, with 529 units recalled in the U.S. Medtronic advised healthcare providers to monitor affected patients and consider further imaging and antiplatelet therapy.
**Serious Risks of Medtronic's MindFrame Capture LLP Revascularization Device: What Patients Need to Know**
April 5, 2024
Taxotere Lawsuit Lawyers
Taxotere, a chemotherapy drug produced by Sanofi, has been linked to permanent hair loss, or alopecia, in patients, unlike other treatments where hair typically regrows. This side effect can severely impact survivors' self-esteem and mental health. Despite awareness of these risks, Taxotere remains in use. Affected individuals may be eligible for financial compensation. Legal assistance is available to explore claims against Sanofi for failing to adequately warn about this side effect. Parker Waichman LLP offers free consultations to discuss potential lawsuits for those impacted by Taxotere-related hair loss.
Get Justice: Claim Your Compensation for Permanent Hair Loss from Taxotere
April 5, 2024
U.K. Claims Against DePuy For Failed Pinnacle Hip Implants
Hundreds of U.K. residents have filed claims against DePuy for defective Pinnacle Ultamet hip implants, which failed prematurely, causing pain and requiring revision surgery. The implants' metal-on-metal design releases toxic chromium and cobalt particles, leading to severe health issues like tissue necrosis and numbness. The High Court in England will determine if DePuy met safety standards. Despite U.S. juries awarding over $1 billion in similar cases, DePuy denies wrongdoing. The lawsuit could become one of the largest product liability cases in England, with potential for thousands more claims.
Claims Against DePuy: Defective Pinnacle Ultamet Hip Replacement Implants and Health Risks
April 5, 2024
Why Hire A Mirena IUD Lawyers?
To create a more general informational tone, remove promotional language and specific references to Parker Waichman LLP. Replace direct promotions with suggestions to contact a qualified attorney. Simplify contact information by removing specific directives and phone numbers, suggesting instead to schedule a consultation with a legal professional. Use neutral language by generalizing services and eliminating branding. Retain general legal process information but remove firm-specific claims. Adjust FAQs to focus on general experience rather than firm-specific achievements. Replace firm-specific statements with references to experienced legal firms.
Mirena IUD Injury Lawsuits: Get the Compensation You Deserve with Expert Legal Help
.svg){kind=small}
.avif)
.avif)